The Role of Inflammasomes in Heart Failure
Panayotis K. Vlachakis, Panagiotis Theofilis, Ioannis Kachrimanidis, Κωνσταντίνος Γιαννακόπουλος, Maria Drakopoulou, Anastasiοs Apostolos, Athanasios Kordalis, Ioannis Leontsinis, Konstantinos Tsioufis, Dimitris Tousoulis
Abstract
Heart failure (HF) poses a significant world health challenge due to the increase in the aging population and advancements in cardiac care. In the pathophysiology of HF, the inflammasome has been correlated with the development, progression, and complications of HF disease. Discovering biomarkers linked to inflammasomes enhances understanding of HF diagnosis and prognosis. Directing inflammasome signaling emerges as an innovative therapeutic strategy for managing HF. The present review aims to delve into this inflammatory cascade, understanding its role in the development of HF, its potential role as biomarker, as well as the prospects of modulating inflammasomes as a therapeutic approach for HF.